triple-negative breast neoplasms | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 79,714 条关于 “triple-negative breast neoplasms”

Onchilles Pharma Receives FDA Clearance for First-in-Class ELANE Pathway Cancer Therapeutic N17350

mTNBC Pipeline Shows Promise with Novel Therapies in Clinical Trials

Sugar-Coated Nanoparticles Show Promise for Triple-Negative Breast Cancer Treatment

Keynote-522 Trial Demonstrates Overall Survival Benefit with Pembrolizumab in Triple-Negative Breast Cancer

Evolving Definition of Triple-Negative Breast Cancer Drives Novel Treatment Approaches

Cleveland Clinic Presents Promising Data on Triple-Negative Breast Cancer Vaccine

Novel Iron-Based Nanoparticles Could Revolutionize Triple-Negative Breast Cancer Treatment

MUSC Launches Clinical Trial for Heart-Safe Triple-Negative Breast Cancer Treatment

Racial Disparities Persist in Triple-Negative Breast Cancer Trials Despite Treatment Advances

Genetic Testing and Sequencing Essential in Metastatic Triple-Negative Breast Cancer, Expert Urges

第 1 页，共 1448 页